Table 1.

Outcomes of study participants

	HR (95% CI) (Unadjusted)	P value	HR (95% CI) (Adjusted*)	P value	HR (95% CI) (Adjusted†)	P value
Low HDL-C	Ref		Ref		Ref
High HDL-C	0.24 (0.09 to 0.67)	0.006	0.28 (0.10 to 0.80)	0.018	0.27 (0.09 to 0.79)	0.017

The endpoint was defined as the first detection of anthracycline-induced subclinical cardiotoxicity.

Low HDL-C: <1.16 mmol/L. High HDL-C: ≥1.16 mmol/L.

*Adjusted for age and sex.

†Adjusted for age, sex, hypertension, body mass index and E.

HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio.